News
-
-
PRESS RELEASE
Galimedix Therapeutics presents further scientific data showing disease-modifying potential of oral GAL-201 in Alzheimer’s disease as well as beneficial effects on synaptic function and neuroimmunomod
Galimedix Therapeutics presents new preclinical data on GAL-201 at AD/PD 2025, showing promise in Alzheimer’s disease treatment by targeting misfolded Aβ monomers and reducing Aβ plaques with anti-inflammatory effects -
-
-
-
PRESS RELEASE
Tarkett unveils industry-first sustainability statement in line with new EU legislation
Tarkett releases its 2024 Sustainability Statement complying with EU CSRD legislation. The company achieves significant sustainability milestones including recycled materials usage and greenhouse gas emissions reduction -
PRESS RELEASE
Tarkett dévoile son état de durabilité aligné avec la nouvelle législation européenne, une première dans l’industrie
Tarkett dévoile son état de durabilité aligné avec la nouvelle législation européenne, une première dans l’industrie. Découvrez les réalisations clés en matière de développement durable pour 2024 -
-
PRESS RELEASE
Corporate Distress on the Rise in Switzerland, Mirroring Broader European Trends
Alvarez & Marsal's Distress Alert report shows corporate distress on the rise in Switzerland, reflecting broader European trends. 8% of Swiss companies face financial distress, signaling economic challenges -
